LG Life Sciences

NCT02831361

Phase 3Completed2016290 people13 Jul 2016clinicaltrials.gov

NCT02670070

Phase 1Status unknown201637 people1 Feb 2016clinicaltrials.gov

NCT02670018

Phase 1Status unknown201525 people1 Feb 2016clinicaltrials.gov

NCT02250872

CollaboratorPhase 2/3Status unknown2014182 people26 Sept 2014clinicaltrials.gov

NCT02056600

Phase 1Completed201424 people6 Feb 2014clinicaltrials.gov

NCT01918332

Phase 3Completed2012168 people7 Aug 2013clinicaltrials.gov

NCT01890629

Phase 4Completed201369 people2 Jul 2013clinicaltrials.gov

NCT01823133

Phase 1Completed201330 people4 Apr 2013clinicaltrials.gov

NCT01787396

Phase 3Completed2013433 people8 Feb 2013clinicaltrials.gov

NCT01768455

Phase 1Completed201327 people15 Jan 2013clinicaltrials.gov

NCT01662674

Phase 1Completed201227 people10 Aug 2012clinicaltrials.gov

NCT01595880

Phase 1Completed201429 people10 May 2012clinicaltrials.gov

NCT01426399

Phase 1Completed201130 people31 Aug 2011clinicaltrials.gov

NCT01001013

Phase 1Completed200924 people23 Oct 2009clinicaltrials.gov

NCT00294619

Phase 3Completed2006147 people22 Feb 2006clinicaltrials.gov

NCT00271518

Phase 3Status unknown2005144 people2 Jan 2006clinicaltrials.gov